SCHEDULE 13D/A: Deep Track Capital Launches Proxy Contest at Dynavax, Nominates Four Directors and Seeks Bylaw Revisions

Activist investor Deep Track Capital, holding a 13.5% stake in Dynavax Technologies Corporation, has formally notified the company of its intent to nominate four director candidates and propose a bylaw repeal at the upcoming 2025 annual meeting.

Summary

• Deep Track Capital, along with its affiliates, has filed an Amendment No. 2 to Schedule 13D, disclosing its 13.5% beneficial ownership, totaling 17,791,486 shares, in Dynavax Technologies Corporation.
• On February 18, 2025, Deep Track submitted a formal notice to Dynavax of its intent to nominate four candidates for election to the Board of Directors at the 2025 Annual Meeting of Stockholders.
• The nominated candidates are Brett A. Erkman, Jeffrey S. Farrow, Michael Mullette, and Donald J. Santel.
• Deep Track also submitted a stockholder proposal aimed at repealing any bylaw provisions or amendments adopted by the Board without stockholder approval since November 6, 2018, up to the conclusion of the 2025 Annual Meeting.
• The Reporting Persons intend to file a preliminary proxy statement with the SEC to solicit proxies in favor of their nominees and the bylaw proposal.
• Deep Track has entered into engagement and indemnification agreements with three of the nominees (Jeffrey S. Farrow, Michael Mullette, and Donald J. Santel), agreeing to indemnify them, reimburse reasonable expenses, and provide compensation of $10,000 upfront and an additional $20,000 upon certain conditions related to their nomination or election.

Sentiment

Score: 6

Explanation: The filing indicates an activist investor's intent to initiate a proxy contest and propose governance changes, which can be disruptive for the company but may be viewed positively by shareholders seeking improved oversight and strategic direction.

Positives

• The activist investor's actions could lead to enhanced corporate governance and potentially improved strategic direction for Dynavax, benefiting long-term shareholders.
• The nomination of new directors could bring fresh perspectives and expertise to the Board, potentially leading to better decision-making.
• The proposal to repeal board-adopted bylaws without stockholder approval could increase shareholder democracy and oversight, aligning governance more closely with shareholder interests.

Negatives

• The initiation of a proxy contest can be disruptive and costly for the company, potentially diverting management's focus from core business operations and strategic initiatives.
• Uncertainty surrounding the outcome of the proxy fight could create volatility in the company's stock price.
• Potential for increased legal and advisory fees for both the company and the activist investor due to the contested election.

Risks

• Proxy Contest: Dynavax Technologies Corporation will likely face a contested election at its 2025 Annual Meeting, which can be resource-intensive and distracting for the company.
• Management Distraction: The company's management time and resources may be diverted to address the proxy fight rather than focusing on business operations and growth initiatives.
• Uncertainty: The outcome of the director nominations and the bylaw proposal is uncertain, which could impact investor confidence and the company's future strategic direction.
• Bylaw Changes: The proposed bylaw repeal could significantly alter the company's governance structure, potentially impacting future board actions and corporate flexibility.

Future Outlook

Deep Track Capital intends to file a preliminary proxy statement with the SEC in connection with the solicitation of proxies for the election of its nominated directors and the approval of the bylaw proposal at the 2025 Annual Meeting of Stockholders.

Industry Context

This filing represents a classic example of activist investing, where a significant shareholder seeks to influence corporate strategy and governance through board nominations and shareholder proposals. Such actions are common across various sectors, including biotechnology, where companies often face scrutiny over R&D pipelines, commercialization strategies, and capital allocation. Deep Track Capital's move suggests a belief that Dynavax's current management or board structure is not maximizing shareholder value.

Management Changes

Corporate Governance

Related Party Transactions

• Deep Track Capital has entered into engagement and indemnification agreements with three of its director nominees (Jeffrey S. Farrow, Michael Mullette, and Donald J. Santel), providing them with compensation ($10,000 upfront and $20,000 upon certain conditions) and indemnification for their roles in the proxy solicitation.

Stakeholder Impact

• Shareholders: Potential for increased shareholder influence over corporate governance and strategic direction; potential for stock price volatility due to the proxy contest; potential for improved long-term value if activist initiatives are successful.
• Management/Board: Faces a challenge to their current control and strategic direction; increased workload and potential distraction due to the proxy contest, diverting focus from day-to-day operations.
• Employees: Potential for uncertainty regarding future strategic direction and leadership, though direct operational impact is not specified in this filing.

Next Steps

• Deep Track Capital intends to file a preliminary proxy statement with the SEC in connection with the proxy solicitation.
• The 2025 Annual Meeting of Stockholders of Dynavax Technologies Corporation will be held, where the nominated directors and the bylaw proposal will be considered for a vote.

Key Dates

Recommendation

Keywords

Dynavax Technologies Corporation, Deep Track Capital, Schedule 13D, Activist Investor, Proxy Contest, Board Nomination, Corporate Governance, Stockholder Proposal, Bylaws, DVAX